As far as liver enzyme reduction is concerned, probiotic supplementation has shown promising results in reducing liver enzyme levels, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST), in patients with NAFLD. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.